Brain metastasis (BrM) is the most common form of brain cancer, characterized by neurologic disability and an abysmal prognosis. Unfortunately, our understanding of the biology underlying human BrMs remains rudimentary. Here, we present an integrative analysis of >100,000 malignant and non-malignant cells from 15 human parenchymal BrMs, generated by single-cell transcriptomics, mass cytometry, and complemented with mouse model- and in silico approaches. We interrogated the composition of BrM niches, molecularly defined the blood-tumor interface, and revealed stromal immunosuppressive states enriched with infiltrated T cells and macrophages. Specific single-cell interrogation of metastatic tumor cells provides a framework of 8 functi...
Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations...
Abstract: Metastasis to the central nervous system (CNS) remains a major cause of morbidity and mort...
Secondary tumours in the brain account for 40 % of triple negative breast cancer patients, and the p...
Brain metastasis (BrM) is the most common form of brain cancer, characterized by neurologic disabili...
Metastasis is the main cause of treatment failure and death in cancer patients. Metastasis of tumor ...
The brain is a major site of relapse for several cancers, yet deciphering the mechanisms of brain me...
Brain metastases (BrMs) are the most common form of brain tumors in adults and frequently originate ...
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma; yet, our under...
Despite constant progress in basic and translational research, cancer is still one of the leading ca...
The microenvironment has emerged as a promising source of novel therapeutic applications in experime...
Bone marrow metastasis frequently occurs in patients with solid cancers and most often leads to poor...
Cellular and non-cellular components of the tumor microenvironment (TME) are emerging as key regulat...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Brain metastasis is a frequent occurrence in cancer patients and carries a high mortality rate. The ...
Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations...
Abstract: Metastasis to the central nervous system (CNS) remains a major cause of morbidity and mort...
Secondary tumours in the brain account for 40 % of triple negative breast cancer patients, and the p...
Brain metastasis (BrM) is the most common form of brain cancer, characterized by neurologic disabili...
Metastasis is the main cause of treatment failure and death in cancer patients. Metastasis of tumor ...
The brain is a major site of relapse for several cancers, yet deciphering the mechanisms of brain me...
Brain metastases (BrMs) are the most common form of brain tumors in adults and frequently originate ...
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma; yet, our under...
Despite constant progress in basic and translational research, cancer is still one of the leading ca...
The microenvironment has emerged as a promising source of novel therapeutic applications in experime...
Bone marrow metastasis frequently occurs in patients with solid cancers and most often leads to poor...
Cellular and non-cellular components of the tumor microenvironment (TME) are emerging as key regulat...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Brain metastasis is a frequent occurrence in cancer patients and carries a high mortality rate. The ...
Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations...
Abstract: Metastasis to the central nervous system (CNS) remains a major cause of morbidity and mort...
Secondary tumours in the brain account for 40 % of triple negative breast cancer patients, and the p...